HOME >> MEDICINE >> NEWS
First US SARS vaccine trial opens at NIH

Powerful research tools that speed up vaccine development have led to the start today of human tests for a preventive vaccine against the respiratory disease SARS. The disease killed hundreds of people around the world before it was brought under control in 2003 with aggressive conventional public health measures.

Researchers at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will conduct the trials. The experimental vaccine against SARS, or severe acute respiratory syndrome, will be tested on 10 healthy volunteers at the NIH Clinical Center in Bethesda, MD. The clinic will do periodic follow-up exams on each volunteer for 32 weeks.

"This experimental vaccine is an outstanding achievement by NIAID researchers," said Health and Human Services Secretary Tommy G. Thompson. "It is a model for research that could greatly shorten the time needed to create vaccines to be tested against other diseases."

"The Vaccine Research Center, a cutting-edge facility established here at NIH just five years ago, encompasses the entire spectrum of vaccine development from basic research to clinical testing," says NIH Director Elias A. Zerhouni, M.D. "This is why our team at NIAID has been able to develop this vaccine at an unprecedented pace, using technological discoveries that were not available just a few short years ago."

The primary goal of the study is to determine if the experimental vaccine is safe in people. A secondary goal is to assess how well the vaccine stimulates the immune system to produce antibodies and cellular immunity, in this case, focusing on the SARS spike protein. The spike protein protrudes from the virus' outer envelope and helps it bind to cells it infects.

SARS was spotted first in China in November 2002. The virus sickened 8,096 and killed 774 worldwide by July 2003, according to the World Health Organization (WHO). SARS was
'"/>

Contact: Linda Joy
ljoy@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
13-Dec-2004


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2018)... SAN JOSE, Calif. (PRWEB) , ... December 07, ... ... reputable orthopedic surgeon who serves the San Francisco Bay area with ... in his field, and he recognizes the importance of educating patients on the ...
(Date:12/6/2018)... ... December 06, 2018 , ... HMP, a leader in healthcare ... The meeting will take place May 9–10, 2019, and will be co-located with ... Antonio, Texas. , PACS is uniquely designed to provide nurses with the important ...
(Date:12/5/2018)... Pa. (PRWEB) , ... December 05, 2018 , ... ... New Vitae Wellness and Recovery , has been reappointed to serve on Philadelphia ... creating policies that support inclusion of those who identify with a cognitive or ...
(Date:12/5/2018)... ... December 05, 2018 , ... Marking its seventh year, ... celebration “A Toast Heard ‘Round the World” on New Year’s Eve. Each year ... global community (alumni, students, faculty members, staff, families, and friends of the institution) to ...
(Date:12/5/2018)... ... 2018 , ... Northcentral University (NCU) has today announced the launch of two ... a weekly rolling basis to registered nurses, the Master of Science in Nursing ... will prepare degree candidates to become leaders in the high-demand field. , “In ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... Join the BFE ... is an interdisciplinary biofeedback conference to nurture communication and education between specialists from ... disciplines come together to share and learn. The meeting offers a broad range ...
(Date:12/5/2018)... ... December 05, 2018 , ... NDA Partners Chairman ... Director of Global Laboratory Integration at the United States Pharmacopeial Convention (USP), has ... executive with extensive experience in domestic and international operations harmonization, compendial affairs, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for Health ... launch of the Annatto-E™ product line, containing unique and natural vitamin E tocotrienols ... DFH’s new Annatto-E™ products are available in three dosages of 75mg (with black ...
Breaking Medicine Technology:
Cached News: